International Clinical Trial: A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133828) titled 'A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Biogen

Condition: Healthy Volunteer

Intervention: Drug: BIIB142

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: August 29, 2025

Target Sample Size: 78

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07133828

Published by HT D...